The rhenium(I)-diselenoether anticancer drug targets ROS,...

  • Main
  • 2019 / 1
  • The rhenium(I)-diselenoether anticancer drug targets ROS,...
Investigational New Drugs 2019 / 1

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

Collery, Philippe, Veena, Vijay, Harikrishnan, Adhikesavan, Desmaele, Didier
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00727-1
Date:
January, 2019
File:
PDF, 1.31 MB
english, 2019
Conversion to is in progress
Conversion to is failed